SHAPE is a non-profit medical organization dedicated to the mission of eradicating heart attacks. Learn more…
Letter to the New Director of Medicare Program Re: Coronary Artery Calcium Score Coverage
Progress in the Integrated Care of Screen-Identified Disease: Lung Cancer and Coronary Artery Diseases
Morteza Naghavi, MD, Society for Heart Attack Prevention and Eradication (SHAPE)
Mayo Clinic Cardiovascular Grand Round
“Machine Learning Asymptomatic Vulnerable ASCVD Patients;
Predicting Heart Attacks like Hurricanes”
Morteza Naghavi, M.D.
Founder and President of SHAPE (Society for Heart Attack Prevention and Eradication)
For the First Time in United States CMS (Center for Medicare and Medicaid Services) Receives a Formal Proposal from SHAPE Doctors for National Coverage Determination (NCD) for Coronary Artery Calcium Score Coverage
Leading cardiologists and cardiovascular researchers praised this effort as a historical bold move that was long due.
Coronary artery calcium testing: A call for universal coverage
Morteza Naghavi, M.D., David Maron, M.D., Robert Kloner, M.D., Ph.D., Daniel Berman, M.D., Mathew Budoff, M.D., Robert Superko, M.D., P.K. Shah, M.D.
SHAPE President Welcomes Addition of Coronary Calcium Scanning to New AHA/ACC Heart Disease Prevention Guidelines Calls It “A Long Time Coming”
Doctors Request CNN to Correct Disinformation Quoted from
Dr. Nissen; Coronary Calcium Scan Costs <$200 Not “$800-$1,000”
The 2nd Machine Learning Vulnerable Patient Symposium
Focused on Developing an
Artificial Intelligence-based Forecast System for Short-Term CVD Events
A Satellite Event in Conjunction with
2017 Annual Scientific Sessions of American Heart Association
November 13, 7-10 PM
Imagine if heart attack and stroke were predicted similarly to hurricanes Harvey and Irma with sufficient short-term alerts to at-risk people to take preventive actions. Read more…
In a letter to SHAPE-Centers of Excellence and other prominent cardiologists, Drs. Naghavi, Budoff, Maron and Berman announced an exciting hypothesis to be tested in TACT-II CAC sub-study which if proven can change the way millions of patients are treated for prevention of heart attacks. Learn more…
The First Machine Learning Vulnerable Patient Symposium
A Focus Group Meeting on Developing an Artificial Intelligence-based Forecast System for Prediction of Heart Attacks within 12 Months
Le Meridien Hotel, New Orleans, LA
November 14, 7-10 PM
Featured Coverage of SHAPE Guidelines Release
Featured Presentations from the 2004 Vulnerable Patient Symposium
A Satellite Event during the Annual Scientific Sessions of American College of Cardiology 2004, New Orleans
Click here to view all presentations
12 years have passed since this symposium and SHAPE is still searching for the answers to these questions: “How can we detect the Vulnerable Patients before a heart attack? and how can we save them?“
Eugene Braunwald, M.D. – Harvard Medical School, Boston, USA
Approach to Identifying and Managing Coronary Risk PowerPoint Slides (Download)
Douglas Zipes, M.D. – Indiana University, Indianapolis, USA
Screening for Vulnerable Myocardium:What are Preceding Triggers of a Fatal Arrhythmia? PowerPoint Slides (Download)
Valentin Fuster, M.D., Ph.D. – Mount Sinai Hospital, New York, USA
CT / MRI for Risk Stratification and Identification of the Vulnerable Patient Transcript (PDF)
Attilio Maseri, M.D. – Universita Vita-Salute San Raffaele, Milan, Italy
Clinical Characteristics of Pre-Symptomatic Vulnerable Patients; Are There Different Types? PowerPoint Slides (Download)
The Scientific Foundation of SHAPE and the SHAPE Task Force Report:
From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I and II
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. Circulation. 2003 Oct 14;108(15):1772-8. PMID: 14557340
From Vulnerable Plaque to Vulnerable Patient—Part III: SHAPE Guidelines
Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force. Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. PMID: 16843744 Download Both in .PDF
From Vulnerable Plaque to Vulnerable Patient
The underlying cause of fatal and non-fatal heart attacks
Written by Dr. Morteza Naghavi, illustrated by Mark Johnson
In 2001, Dr. Naghavi, the founder of SHAPE invited cardiology leaders to answer these 10 questions. Now, after 15 years it is interesting to review their answers and compare the predictions with reality. Click here to view
SHAPE Congratulates Dr. MacRae and Team for Winning the $75 Million One Brave Idea Award To End Coronary Heart Disease
SHAPE Golf Fore Heart 2016 – Guy P. Fernandez Memorial Golf Tournament
The 10th annual Golf Fore Heart Tournament at the Mountain Branch Golf Club in Joppa, MD took place on June 22, 2016. The event was organized by JoAnne Zawitoski, the chairwoman of SHAPE and Mark Montgomery who co-chaired the event in the past 10 years. Read more…
SHAPE Urges to Move from Vulnerable Plaque to Vulnerable Patient
Since the SHAPE movement roots in the early days of “Vulnerable Plaque” era, on behalf of the SHAPE Task Force, I would like to bring the following to your attention. Read more…
SHAPE Redoubles Commitment to Eradicate Heart Attacks and Embarks on Fundraising for SHAPE Trial
Leading cardiovascular physicians and researchers gathered at SHAPE Trial Advisory meeting to chart the course for perfecting early detection of patients vulnerable to heart attack Read more The SHAPE Trial Advisory Meeting, August 21-23, 2015, Los Angeles – Marina del Ray, CA Ritz-Carlton Hotel, Marina Vista Conference Room
Day 1: Necessity, Feasibility, Design, Implementation, and Fundraising for a Longitudinal Outcome Study to Compare SHAPE Guidelines with the Status Quo Day 2: Public Healthcare Policies and Regulatory Initiatives, SHAPE Centers of Excellence.
View Speaker Presentations
* ***The SHAPE Trial Advisory Meeting – Part II***
A satellite event in conjunction with 2015 Annual Scientific Sessions of American Heart Association – Rosen Plaza Hotel, Orlando, FL Nov 9th, 2015, 7 pm – 9 pm PST (Dinner will be served) –View Agenda
The Latest on Coronary Calcium and Carotid/Femoral Plaque-Based Risk Assessment for Early Detection and Treatment of Atherosclerotic Cardiovascular Disease Nov 4th, 2015, 10 am – 12 noon PST View Agenda Click here to watch recorded webinar!
The SHAPE Accredited Centers Of Excellence Program Is A Scientifically Validated And Guideline-Based Approach To Early Detection Of Coronary Artery Disease.
Six Additional East Texas Medical Center Hospitals Certified as SHAPE Centers of Excellence
A major step toward improving patient outcomes through early detection and prevention of coronary artery disease the number 1 killer….. Read more
The SHAPE Accredited Centers of Excellence program is a scientifically validated and guideline-based approach to early detection of Coronary Artery Disease.
Learn more about the program and how it has emerged as the next step for improving heart health worldwide.
SHAPE Applauds U.S. Preventive Services Task Force for Seeking the Truth about Coronary Artery Calcium
[contact-form-7 id=”23740″ title=”Contact form 1″]
order SHAPE BOOK
[feedzy-rss feeds="https://newsroom.heart.org/rss.xml" max="5" summarylength="100" feed_title="no" thumb="no"]
[efb_likebox fanpage_url=”SHAPESociety” box_width=”270″ box_height=”450″ locale=”en_US” responsive=”0″ show_faces=”1″ show_stream=”0″ hide_cover=”0″ small_header=”0″ hide_cta=”0″ ]
Dr. Bhambi has been in practice with Central Cardiology Medical Clinic in Bakersfield, CA for 22 years
Primary Prevention Of Atherosclerotic Cardiovascular Disease
Non-invasive Screening – Polypill Therapy – Vaccination
Therapy in High Risk Population Valentin Fuster, M.D., Ph.D., Director of Mount Sinai Heart, the Zena and Michael.
Morteza Naghavi, M.D.,
Dr. Morteza Naghavi, is the founder of SHAPE and executive chairman of the SHAPE Task Force. Dr. Naghavi is also president of MEDITEX.
Mathew Budoff, MD.,
Vice President, Society of Atherosclerosis Imaging; Professor of Medicine and Director of Preventive Cardiology, UCLA Harbor Los Angeles, CA
P.K. Shah, MD.,
Chairman of SHAPE Scientific Committee; Director, Division of Cardiology; Director, Oppenheimer Atherosclerosis Research Center.
Associate Director of Cardiovascular Imaging, Mount Sinai Medical Center, New York; Professor of Medicine, Icahn School of Medicine at Mount Sinai, New York
Jay N. Cohn, M.D.
Professor of Medicine, Director, Rasmussen Center for Cardiovascular Disease Prevention, University of Minnesota, Cardiology Division, Minneapolis, MN
Chief of Cardiac Imaging and Nuclear Cardiology; Medical Director of Artificial Intelligence in Medicine Program; Professor of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA
Tasneem Z. Naqvi, MD is Associate Director of the Cardiac Noninvasive Laboratory and Director of Interventional Echocardiography at Cedars-Sinai Medical Center in the Division of Cardiology.